Banque Cantonale Vaudoise Ab Cellera Biologics Inc. Transaction History

Banque Cantonale Vaudoise

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$7.31 - $11.18 $195,849 - $299,534	-26,792 Reduced 81.0%	6,284 $47,000
Q4 2022 Feb 10, 2023	SELL	$9.48 - $14.52 $103,350 - $158,297	-10,902 Reduced 24.79%	33,076 $335,000
Q3 2022 Oct 17, 2022	BUY	$9.2 - $13.68 $346,784 - $515,653	37,694 Added 599.84%	43,978 $435,000
Q2 2022 Aug 02, 2022	BUY	$5.72 - $10.65 $35,944 - $66,924	6,284 New	6,284 $67,000

154

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $841M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Banque Cantonale Vaudoise, based on Form 13F filings with the SEC.

Stay updated on Banque Cantonale Vaudoise with notifications on news.